IP Library › Assignment 055402/0611
Patent Assignment
Reel/Frame 055402/0611

Change of Name

Recorded: 2021-02-24 Pages: 3
Assignor
GALENA BIOPHARMA, INC.
Executed: 2017-12-29
Assignee
SELLAS LIFE SCIENCES GROUP, INC.
315 MADISON AVENUE, 4TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties (3)
Peptide Vaccine Therapy for Treatment of Fra-Expressing Tumors
Patent: 9,993,538 →
Application: 15/169,328 →
Publication: US 2017/0007687
Vaccine Therapy for Treatment of Endometrial and Ovarian Cancer
Application: 15/872,626 →
Publication: US 2018/0256692
PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS
Application: 17/101,985 →
Publication: US 2021/0213115
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 15, 2021
From: PEOPLES, GEORGE E.
To: SELLAS LIFE SCIENCES GROUP, INC.
Reel/Frame 055591/0797 →
Assignment of Assignor's Interest Mar 26, 2021
From: SELLAS LIFE SCIENCES GROUP, INC.
To: THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.
Reel/Frame 055745/0777 →